• Profile
Close

Predictors of mortality in patients with non-anterior ST-segment elevation myocardial infarction: Analysis from the HORIZONS-AMI trial

Catheterization and Cardiovascular Interventions Aug 13, 2019

Huang X, Redfors B, Chen S, et al. - From the Harmonizing Outcomes With Revascularization and Stents in Acute Myocardial Infarction trial, researchers examined patients with non-anterior ST-elevation myocardial infarction (NA-STEMI) to determine clinical, electrocardiographic, and angiographic features that are predictive of 3-year mortality following primary percutaneous coronary intervention (PCI) in this population. A better prognosis was reported in NA-STEMI vs anterior STEMI but high-risk patient cohorts with NA-STEMI having substantial 3-year mortality may be identified. Older age (median > 59.0 years), diabetes, reduced LVEF (≤ 50%), Killip class ≥ 2, postprocedure TIMI flow 0–2 vs 3, renal insufficiency, and ST-resolution < 30% at 60 min post-PCI were all identified as independent predictors of increased 3-year mortality in NA-STEMI. The reported 3-year mortality rates for patients with 0, 1, 2, 3, and ≥ 4 of these risk factors were 1.8%, 2.3%, 3.1%, 6.1%, and 36.3%, respectively.
Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
  • Exclusive Write-ups & Webinars by KOLs

  • Nonloggedininfinity icon
    Daily Quiz by specialty
  • Nonloggedinlock icon
    Paid Market Research Surveys
  • Case discussions, News & Journals' summaries
Sign-up / Log In
x
M3 app logo
Choose easy access to M3 India from your mobile!


M3 instruc arrow
Add M3 India to your Home screen
Tap  Chrome menu  and select "Add to Home screen" to pin the M3 India App to your Home screen
Okay